Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Advanced Acute Leukemia

During this trial, researchers investigated the efficacy of high dose per fraction TMI in combination with thiotepa, fludarabine, and melphalan among 13 consecutive patients with acute leukemia who had relapsed after a first allogeneic HSCT treated between March 2018 and November 2021.

Access the full article to read more here.